APO RESEARCH · REPORT
Medical Grade Chitosan
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Product & engineering
Understand the product.
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Selected research
Industry Research
Medical Grade Chitosan Industry Research Report 2026
Market perspective
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
Report Scope
Read the full market overview
This report quantifies the global Medical Grade Chitosan market in terms of revenue (US$ million) and, where applicable, sales volume (Ton), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Ton) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Grade Chitosan Market by Company
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Medical Grade Chitosan Segment by Type
Animal Origin Chitosan
Plant Based Chitosan
Medical Grade Chitosan Segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others
Medical Grade Chitosan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Grade Chitosan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Grade Chitosan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Grade Chitosan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Grade Chitosan manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Grade Chitosan by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Grade Chitosan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Animal Origin Chitosan
- Plant Based Chitosan
Applications
- Wound Care
- Healthcare Products
- Antibacterial Products
- Others
Companies covered
- Primex
- KitoZyme
- BIO21
- YSK
- Vietnam Food
- NovaMatrix
- KIMICA
- Ningbo Zhenhai Haixin Biological
- Golden-Shell Pharmaceutical
- Zhejiang Fengrun Biotech
- Jiangsu Shuanglin
- Jiangsu Aoxin Biotechnology
- Qingdao Yunzhou Biochemistry
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Grade Chitosan Market Size (2021-2032)
- 2.2.2 Global Medical Grade Chitosan Sales (2021-2032)
- 2.2.3 Global Medical Grade Chitosan Market Average Price (2021-2032)
- 2.3 Medical Grade Chitosan by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Animal Origin Chitosan
- 2.3.3 Plant Based Chitosan
- 2.4 Medical Grade Chitosan by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Wound Care
- 2.4.3 Healthcare Products
- 2.4.4 Antibacterial Products
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Grade Chitosan Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Grade Chitosan Sales (Ton) of Manufacturers (2021-2026)
- 3.3 Global Medical Grade Chitosan Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Grade Chitosan Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Grade Chitosan Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Grade Chitosan, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Grade Chitosan, Product Type & Application
- 3.8 Global Manufacturers of Medical Grade Chitosan, Established Date
- 3.9 Global Medical Grade Chitosan Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Primex
- 4.1.1 Primex Company Information
- 4.1.2 Primex Business Overview
- 4.1.3 Primex Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Primex Medical Grade Chitosan Product Portfolio
- 4.1.5 Primex Recent Developments
- 4.2 KitoZyme
- 4.2.1 KitoZyme Company Information
- 4.2.2 KitoZyme Business Overview
- 4.2.3 KitoZyme Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 KitoZyme Medical Grade Chitosan Product Portfolio
- 4.2.5 KitoZyme Recent Developments
- 4.3 BIO21
- 4.3.1 BIO21 Company Information
- 4.3.2 BIO21 Business Overview
- 4.3.3 BIO21 Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BIO21 Medical Grade Chitosan Product Portfolio
- 4.3.5 BIO21 Recent Developments
- 4.4 YSK
- 4.4.1 YSK Company Information
- 4.4.2 YSK Business Overview
- 4.4.3 YSK Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 YSK Medical Grade Chitosan Product Portfolio
- 4.4.5 YSK Recent Developments
- 4.5 Vietnam Food
- 4.5.1 Vietnam Food Company Information
- 4.5.2 Vietnam Food Business Overview
- 4.5.3 Vietnam Food Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vietnam Food Medical Grade Chitosan Product Portfolio
- 4.5.5 Vietnam Food Recent Developments
- 4.6 NovaMatrix
- 4.6.1 NovaMatrix Company Information
- 4.6.2 NovaMatrix Business Overview
- 4.6.3 NovaMatrix Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NovaMatrix Medical Grade Chitosan Product Portfolio
- 4.6.5 NovaMatrix Recent Developments
- 4.7 KIMICA
- 4.7.1 KIMICA Company Information
- 4.7.2 KIMICA Business Overview
- 4.7.3 KIMICA Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 KIMICA Medical Grade Chitosan Product Portfolio
- 4.7.5 KIMICA Recent Developments
- 4.8 Ningbo Zhenhai Haixin Biological
- 4.8.1 Ningbo Zhenhai Haixin Biological Company Information
- 4.8.2 Ningbo Zhenhai Haixin Biological Business Overview
- 4.8.3 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Product Portfolio
- 4.8.5 Ningbo Zhenhai Haixin Biological Recent Developments
- 4.9 Golden-Shell Pharmaceutical
- 4.9.1 Golden-Shell Pharmaceutical Company Information
- 4.9.2 Golden-Shell Pharmaceutical Business Overview
- 4.9.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Golden-Shell Pharmaceutical Medical Grade Chitosan Product Portfolio
- 4.9.5 Golden-Shell Pharmaceutical Recent Developments
- 4.10 Zhejiang Fengrun Biotech
- 4.10.1 Zhejiang Fengrun Biotech Company Information
- 4.10.2 Zhejiang Fengrun Biotech Business Overview
- 4.10.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zhejiang Fengrun Biotech Medical Grade Chitosan Product Portfolio
- 4.10.5 Zhejiang Fengrun Biotech Recent Developments
- 4.11 Jiangsu Shuanglin
- 4.11.1 Jiangsu Shuanglin Company Information
- 4.11.2 Jiangsu Shuanglin Business Overview
- 4.11.3 Jiangsu Shuanglin Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jiangsu Shuanglin Medical Grade Chitosan Product Portfolio
- 4.11.5 Jiangsu Shuanglin Recent Developments
- 4.12 Jiangsu Aoxin Biotechnology
- 4.12.1 Jiangsu Aoxin Biotechnology Company Information
- 4.12.2 Jiangsu Aoxin Biotechnology Business Overview
- 4.12.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product Portfolio
- 4.12.5 Jiangsu Aoxin Biotechnology Recent Developments
- 4.13 Qingdao Yunzhou Biochemistry
- 4.13.1 Qingdao Yunzhou Biochemistry Company Information
- 4.13.2 Qingdao Yunzhou Biochemistry Business Overview
- 4.13.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product Portfolio
- 4.13.5 Qingdao Yunzhou Biochemistry Recent Developments
5 Global Medical Grade Chitosan Market Scenario by Region
- 5.1 Global Medical Grade Chitosan Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Grade Chitosan Sales by Region: 2021-2032
- 5.2.1 Global Medical Grade Chitosan Sales by Region: 2021-2026
- 5.2.2 Global Medical Grade Chitosan Sales by Region: 2027-2032
- 5.3 Global Medical Grade Chitosan Revenue by Region: 2021-2032
- 5.3.1 Global Medical Grade Chitosan Revenue by Region: 2021-2026
- 5.3.2 Global Medical Grade Chitosan Revenue by Region: 2027-2032
- 5.4 North America Medical Grade Chitosan Market Facts & Figures by Country
- 5.4.1 North America Medical Grade Chitosan Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Grade Chitosan Sales by Country (2021-2032)
- 5.4.3 North America Medical Grade Chitosan Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Grade Chitosan Market Facts & Figures by Country
- 5.5.1 Europe Medical Grade Chitosan Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Grade Chitosan Sales by Country (2021-2032)
- 5.5.3 Europe Medical Grade Chitosan Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Grade Chitosan Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Grade Chitosan Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Grade Chitosan Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Grade Chitosan Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Grade Chitosan Market Facts & Figures by Country
- 5.7.1 South America Medical Grade Chitosan Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Grade Chitosan Sales by Country (2021-2032)
- 5.7.3 South America Medical Grade Chitosan Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Grade Chitosan Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Grade Chitosan Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Grade Chitosan Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Grade Chitosan Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Grade Chitosan Sales by Type (2021-2032)
- 6.1.1 Global Medical Grade Chitosan Sales by Type (2021-2032) & (Ton)
- 6.1.2 Global Medical Grade Chitosan Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Grade Chitosan Revenue by Type (2021-2032)
- 6.2.1 Global Medical Grade Chitosan Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Grade Chitosan Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Grade Chitosan Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Grade Chitosan Sales by Application (2021-2032)
- 7.1.1 Global Medical Grade Chitosan Sales by Application (2021-2032) & (Ton)
- 7.1.2 Global Medical Grade Chitosan Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Grade Chitosan Revenue by Application (2021-2032)
- 7.2.1 Global Medical Grade Chitosan Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Grade Chitosan Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Grade Chitosan Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Grade Chitosan Value Chain Analysis
- 8.1.1 Medical Grade Chitosan Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Grade Chitosan Production Mode & Process
- 8.2 Medical Grade Chitosan Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Grade Chitosan Distributors
- 8.2.3 Medical Grade Chitosan Customers
9 Global Medical Grade Chitosan Analyzing Market Dynamics
- 9.1 Medical Grade Chitosan Industry Trends
- 9.2 Medical Grade Chitosan Industry Drivers
- 9.3 Medical Grade Chitosan Industry Opportunities and Challenges
- 9.4 Medical Grade Chitosan Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst